{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:02:26Z","timestamp":1774540946093,"version":"3.50.1"},"publisher-location":"Cham","reference-count":64,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030916213","type":"print"},{"value":"9783030916237","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-91623-7_6","type":"book-chapter","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:02:39Z","timestamp":1647284559000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism"],"prefix":"10.1007","author":[{"given":"Shinya","family":"Nakatani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Razzaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"3","key":"6_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091096","volume":"9","author":"N Arai-Nunota","year":"2014","unstructured":"Arai-Nunota N, Mizobuchi M, Ogata H, Yamazaki-Nakazawa A, Kumata C, Kondo F et al (2014) Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats. PLoS One 9(3):e91096","journal-title":"PLoS One"},{"issue":"1","key":"6_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2012.327","volume":"83","author":"J Arnlov","year":"2013","unstructured":"Arnlov J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, Lind L et al (2013) Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int 83(1):160\u2013166","journal-title":"Kidney Int"},{"issue":"18","key":"6_CR3","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.3390\/ijms20184634","volume":"20","author":"I Bockmann","year":"2019","unstructured":"Bockmann I, Lischka J, Richter B, Deppe J, Rahn A, Fischer DC et al (2019) FGF23-mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis. Int J Mol Sci 20(18):4634","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40620-020-00715-2","volume":"33","author":"A Bouma-De Krijger","year":"2020","unstructured":"Bouma-De Krijger A, Vervloet MG (2020) Fibroblast growth factor 23: are we ready to use it in clinical practice? J Nephrol 33(3):509\u2013527","journal-title":"J Nephrol"},{"issue":"4","key":"6_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1073\/pnas.95.4.1387","volume":"95","author":"HL Brenza","year":"1998","unstructured":"Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H et al (1998) Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci U S A 95(4):1387\u20131391","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072816","volume":"8","author":"A Chanakul","year":"2013","unstructured":"Chanakul A, Zhang MY, Louw A, Armbrecht HJ, Miller WL, Portale AA et al (2013) FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues. PLoS One 8(9):e72816","journal-title":"PLoS One"},{"issue":"4","key":"6_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjmed.2008.09.039","volume":"122","author":"M Chonchol","year":"2009","unstructured":"Chonchol M, Dale R, Schrier RW, Estacio R (2009) Serum phosphorus and cardiovascular mortality in type 2 diabetes. Am J Med 122(4):380\u2013386","journal-title":"Am J Med"},{"issue":"9","key":"6_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044161","volume":"7","author":"B Dai","year":"2012","unstructured":"Dai B, David V, Martin A, Huang J, Li H, Jiao Y et al (2012) A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model. PLoS One 7(9):e44161","journal-title":"PLoS One"},{"issue":"9","key":"6_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1681\/ASN.2010121251","volume":"22","author":"MH De Borst","year":"2011","unstructured":"De Borst MH, Vervloet MG, Ter Wee PM, Navis G (2011) Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 22(9):1603\u20131609","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"6_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000497125","volume":"49","author":"IE Emrich","year":"2019","unstructured":"Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K et al (2019) Strength of fibroblast growth factor 23 as a cardiovascular risk predictor in chronic kidney disease weaken by ProBNP adjustment. Am J Nephrol 49(3):203\u2013211","journal-title":"Am J Nephrol"},{"issue":"11","key":"6_CR11","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"9","key":"6_CR12","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A et al (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18(9):2600\u20132608","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"6_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","volume":"80","author":"RT Gansevoort","year":"2011","unstructured":"Gansevoort RT, Matsushita K, Van Der Velde M, Astor BC, Woodward M, Levey AS et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80(1):93\u2013104","journal-title":"Kidney Int"},{"issue":"7","key":"6_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.69.7.1673","volume":"69","author":"M Garabedian","year":"1972","unstructured":"Garabedian M, Holick MF, Deluca HF, Boyle IT (1972) Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A 69(7):1673\u20131676","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584\u2013592","journal-title":"N Engl J Med"},{"issue":"19","key":"6_CR16","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119(19):2545\u20132552","journal-title":"Circulation"},{"issue":"2","key":"6_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1523-1755.2004.00402.x","volume":"65","author":"JG Hoenderop","year":"2004","unstructured":"Hoenderop JG, Chon H, Gkika D, Bluyssen HA, Holstege FC, St-Arnaud R et al (2004) Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice. Kidney Int 65(2):531\u2013539","journal-title":"Kidney Int"},{"issue":"3","key":"6_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4065\/81.3.353","volume":"81","author":"MF Holick","year":"2006","unstructured":"Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353\u2013373","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266\u2013281","journal-title":"N Engl J Med"},{"issue":"4","key":"6_CR20","doi-asserted-by":"publisher","first-page":"1080S","DOI":"10.1093\/ajcn\/87.4.1080S","volume":"87","author":"MF Holick","year":"2008","unstructured":"Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S\u20131086S","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"6_CR21","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/ndt\/gfu101","volume":"29","author":"JJ Hsu","year":"2014","unstructured":"Hsu JJ, Katz R, Ix JH, De Boer IH, Kestenbaum B, Shlipak MG (2014) Association of fibroblast growth factor-23 with arterial stiffness in the multi-ethnic study of atherosclerosis. Nephrol Dial Transplant 29(11):2099\u20132105","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"6_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro OM et al (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22(1):124\u2013136","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"6_CR23","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00198-006-0154-6","volume":"17","author":"M Inaba","year":"2006","unstructured":"Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T et al (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17(10):1506\u20131513","journal-title":"Osteoporos Int"},{"issue":"12","key":"6_CR24","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"issue":"6","key":"6_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2215\/CJN.09250912","volume":"8","author":"T Isakova","year":"2013","unstructured":"Isakova T, Barchi-Chung A, Enfield G, Smith K, Vargas G, Houston J et al (2013) Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clin J Am Soc Nephrol 8(6):1009\u20131018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"6_CR26","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 24(9):2792\u20132796","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"6_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G et al (2011) FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22(10):1913\u20131922","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"6_CR28","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2215\/CJN.02160212","volume":"7","author":"AM Khan","year":"2012","unstructured":"Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE (2012) FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin J Am Soc Nephrol 7(12):2017\u20132022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"6_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes, CKD-MBD Update WG","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes, CKD-MBD Update WG (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011) 7(1):1\u201359","journal-title":"Kidney Int Suppl (2011)"},{"issue":"4","key":"6_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","volume":"9","author":"F Koiwa","year":"2005","unstructured":"Koiwa F, Kazama JJ, Tokumoto A, Onoda N, Kato H, Okada T et al (2005) Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients. Ther Apher Dial 9(4):336\u2013339","journal-title":"Ther Apher Dial"},{"issue":"9","key":"6_CR31","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/ndt\/gft065","volume":"28","author":"CP Kovesd","year":"2013","unstructured":"Kovesd CP, Quarles LD (2013) Fibroblast growth factor-23: what we know, what we don\u2019t know, and what we need to know. Nephrol Dial Transplant 28(9):2228\u20132236","journal-title":"Nephrol Dial Transplant"},{"issue":"6655","key":"6_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-O","year":"1997","unstructured":"Kuro-O M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390(6655):45\u201351","journal-title":"Nature"},{"issue":"1","key":"6_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"9","key":"6_CR34","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18(9):1731\u20131740","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"6_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1530\/EJE-07-0534","volume":"158","author":"R Marsell","year":"2008","unstructured":"Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellstrom D et al (2008) Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol 158(1):125\u2013129","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"6_CR36","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","volume":"168","author":"ML Melamed","year":"2008","unstructured":"Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629\u20131637","journal-title":"Arch Intern Med"},{"issue":"2","key":"6_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","volume":"205","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205(2):385\u2013390","journal-title":"Atherosclerosis"},{"issue":"9","key":"6_CR38","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/jps.22614","volume":"100","author":"K Miyamoto","year":"2011","unstructured":"Miyamoto K, Haito-Sugino S, Kuwahara S, Ohi A, Nomura K, Ito M et al (2011) Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. J Pharm Sci 100(9):3719\u20133730","journal-title":"J Pharm Sci"},{"issue":"11","key":"6_CR39","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69(11):1945\u20131953","journal-title":"Kidney Int"},{"issue":"2","key":"6_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000430870","volume":"1308","author":"S Nakatani","year":"2015","unstructured":"Nakatani S, Nakatani A, Tsugawa N, Yamada S, Mori K, Imanishi Y et al (2015) Fibroblast growth factor-23 and Vitamin D metabolism in subjects with eGFR >\/=60 ml\/min\/1.73 m2. Nephron 1308(2):119\u2013126","journal-title":"Nephron"},{"issue":"12","key":"6_CR41","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","volume":"70","author":"Y Nishida","year":"2006","unstructured":"Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T et al (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70(12):2141\u20132147","journal-title":"Kidney Int"},{"issue":"2","key":"6_CR42","first-page":"89","volume":"4","author":"N Noori","year":"2010","unstructured":"Noori N, Sims JJ, Kopple JD, Shah A, Colman S, Shinaberger CS et al (2010) Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis 4(2):89\u2013100","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"6_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41598-017-18473-w","volume":"8","author":"E Ozaki","year":"2018","unstructured":"Ozaki E, Yamada S, Kuriyama N, Matsui D, Watanabe I, Koyama T et al (2018) Association of BAP with urinary albumin excretion in postmenopausal, but not premenopausal, non-CKD Japanese women. Sci Rep 8(1):82","journal-title":"Sci Rep"},{"issue":"1","key":"6_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","volume":"33","author":"CW Park","year":"1999","unstructured":"Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY et al (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33(1):73\u201381","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"6_CR45","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M et al (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152(10):640\u2013648","journal-title":"Ann Intern Med"},{"issue":"2","key":"6_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mnc.2003.392","volume":"10","author":"MA Perazella","year":"2003","unstructured":"Perazella MA, Setaro JF (2003) Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders. J Nucl Cardiol 10(2):184\u2013196","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"6_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2265.2011.04147.x","volume":"75","author":"S Pilz","year":"2011","unstructured":"Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zittermann A et al (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 75(5):575\u2013584","journal-title":"Clin Endocrinol"},{"issue":"4","key":"6_CR48","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1074\/jbc.M207872200","volume":"278","author":"H Saito","year":"2003","unstructured":"Saito H, Kusano K, Kinosaki M, Ito H, Hirata M, Segawa H et al (2003) Human fibroblast growth factor-23 mutants suppress Na+^-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278(4):2206\u20132211","journal-title":"J Biol Chem"},{"issue":"6","key":"6_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH et al (2013) Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83(6):1159\u20131168","journal-title":"Kidney Int"},{"issue":"1","key":"6_CR50","doi-asserted-by":"publisher","first-page":"F39","DOI":"10.1152\/ajprenal.00375.2003","volume":"287","author":"H Segawa","year":"2004","unstructured":"Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y et al (2004) Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287(1):F39\u2013F47","journal-title":"Am J Physiol Renal Physiol"},{"issue":"21","key":"6_CR51","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","volume":"32","author":"S Seiler","year":"2011","unstructured":"Seiler S, Cremers B, Rebling NM, Hornof F, Jeken J, Kersting S et al (2011) The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 32(21):2688\u20132696","journal-title":"Eur Heart J"},{"issue":"2","key":"6_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","volume":"44","author":"T Shigematsu","year":"2004","unstructured":"Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F et al (2004) Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44(2):250\u2013256","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"6_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"5","key":"6_CR54","doi-asserted-by":"publisher","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","volume":"289","author":"T Shimada","year":"2005","unstructured":"Shimada T, Yamazaki Y, Takahashi M, Hasegawa H, Urakawa I, Oshima T et al (2005) Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289(5):F1088\u2013F1095","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"6_CR55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.20452\/pamw.1186","volume":"122","author":"A Skalska","year":"2012","unstructured":"Skalska A, Galas A, Grodzicki T et al (2012) 25-hydroxyvitamin D and physical and cognitive performance in older people with chronic conditions. Pol Arch Med Wewn 122(4):162\u2013169","journal-title":"Pol Arch Med Wewn"},{"issue":"10","key":"6_CR56","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1210\/jc.2016-2215","volume":"101","author":"N Souma","year":"2016","unstructured":"Souma N, Isakova T, Lipiszko D, Sacco RL, Elkind MS, Derosa JT et al (2016) Fibroblast growth factor 23 and cause-specific mortality in the general population: the northern Manhattan study. J Clin Endocrinol Metab 101(10):3779\u20133786","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6_CR57","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11255-016-1231-1","volume":"48","author":"MN Turan","year":"2016","unstructured":"Turan MN, Kircelli F, Yaprak M, Sisman AR, Gungor O, Bayraktaroglu S et al (2016) FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients. Int Urol Nephrol 48(4):609\u2013617","journal-title":"Int Urol Nephrol"},{"issue":"7120","key":"6_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770\u2013774","journal-title":"Nature"},{"issue":"3","key":"6_CR59","doi-asserted-by":"publisher","first-page":"C487","DOI":"10.1152\/ajpcell.00412.2001","volume":"282","author":"H Xu","year":"2002","unstructured":"Xu H, Bai L, Collins JF, Ghishan FK (2002) Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). Am J Physiol Cell Physiol 282(3):C487\u2013C493","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"6_CR60","doi-asserted-by":"publisher","first-page":"E2036","DOI":"10.1210\/jc.2012-2024","volume":"97","author":"K Yoda","year":"2012","unstructured":"Yoda K, Imanishi Y, Yoda M, Mishima T, Ichii M, Yamada S et al (2012) Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis. J Clin Endocrinol Metab 97(11):E2036\u2013E2043","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR61","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ndt\/gfq537","volume":"26","author":"HE Yoon","year":"2011","unstructured":"Yoon HE, Ghee JY, Piao S, Song JH, Han DH, Kim S et al (2011) Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 26(3):800\u2013813","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"6_CR62","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1210\/en.2004-0192","volume":"145","author":"B Yuan","year":"2004","unstructured":"Yuan B, Xing Y, Horst RL, Drezner MK (2004) Evidence for abnormal translational regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in the hyp-mouse. Endocrinology 145(8):3804\u20133812","journal-title":"Endocrinology"},{"issue":"3","key":"6_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000316703","volume":"33","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Lin S, Tang R, Veeraragoo P, Peng W, Wu R (2010) Role of Fosinopril and valsartan on klotho gene expression induced by angiotensin II in rat renal tubular epithelial cells. Kidney Blood Press Res 33(3):186\u2013192","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"6_CR64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3945\/ajcn.111.014779","volume":"95","author":"A Zittermann","year":"2012","unstructured":"Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 95(1):91\u2013100","journal-title":"Am J Clin Nutr"}],"container-title":["Advances in Experimental Medicine and Biology","Phosphate Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-91623-7_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:26:32Z","timestamp":1726817192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-91623-7_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030916213","9783030916237"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-91623-7_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}